Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Immunovant, Inc. (IMVT) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Immunovant, Inc. (IMVT) on November 9, 2026 is 34.92 $, +14.40 % on the day. Over 52 weeks the stock traded between 21.43 $ and 45.42 $; the price now sits 56 % of the way up that range. Over the past year the price changed by +15.11 %. Market capitalization is 6.31 billion $, rank 17 among 134 stocks of the same industry with a known capitalization.
Immunovant, Inc. trades on Nasdaq under the ticker IMVT. The company belongs to the Health care sector. The trading history on this page starts on 21 June 2019.
Over the past 52 weeks IMVT has traded between 21.43 $ and 45.42 $. As of 9 November 2026 the price stood 29.10% of the way from the 52-week low to the high.
Over one year IMVT shares rose 15.11%; over six months they rose 2.01%. Volatility over 90 days is 35.18%. Dividends are not included: this is price change only, as of 9 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 8.6, above the sector median of 2.3. Calculated from reports for the period ending 30 June 2026.
IMVT has a return on equity of −73.19%, below the sector median of −40.58%. Return on assets is −63.13%, below the sector median of −30.08%.